Jeff Blue


Jeffrey T. Blue has been with MSD more than 25 years.Through his career, he has led the Vaccine Drug Product Development and New Technologies Department.His department is responsible for the development of both in-line and pipeline early and late stage vaccine programs (LVVs, subunit, mRNA, conjugated) and supports technology transfer of the drug product formulation and process to the final commercial sites.His department is also responsible for supporting novel innovative technologies for drug product development including new drying technologies, novel adjuvants, and alternative delivery for vaccines and biologics (i.e., Patch technology, ID delivery, controlled release etc.).He has published multiple book chapters and various articles on vaccine drug product development and lyophilization. Over the course of his career within MSD, he has championed the development and successful launch of Varivax®, Zostavax®, and ProQuad® vaccines.He has also played an integral role in the development of the Ebola Zaire Vaccine that MSD is currently developing.